Background: Allergy and functional gastrointestinal disorders have been associated with eosinophilia in duodenal mucosa.
The eosinophil is a characteristic bone marrow derived circulating granulocyte with diverse functions; it hosts an array of effector mechanisms important in normal physiology throughout the gastrointestinal (GI) tract of healthy subjects 1 . The only part of the GI tract normally free of eosinophils is the squamous epithelium of the oesophagus 1 . The normal function of the eosinophil in host defence and immune regulation is carried out via effector secretory granules, which effect antigen presentation, cytokine release, mast cell activation, and immune tolerance 2 . Established in their position in host defence against helminths 3, 4 , eosinophils also play an important role in combating bacterial and viral infections 1, 5 . Gastric eosinophilia occurs in H. pylori infection 5 . Dysregulation of eosinophils also occurs in allergic disease, parasite infestation, tumours, drug reactions and hypersensitivity 1 .
Small bowel biopsies from patients with asthma and allergic rhinitis show features in common with the inflammatory reaction observed in the airways, with accumulation of eosinophils 6 . Gastrointestinal symptoms are also significantly more common in patients with asthma and allergic rhinitis 7 . Recently, eosinophils have been implicated in contributing to functional gastrointestinal disorders (FGIDs) 8, 9 . FGIDs, including irritable bowel syndrome (IBS) and functional dyspepsia (FD) are defined by chronic abdominal symptoms not associated with known structural or biochemical pathology 5, 9, 10 . Definitive criteria for FGIDs are arguably problematic owing to the wide spectrum of manifestations and as a result, FGIDs are grouped by symptoms, and there is a considerable overlap of these disorders based on current classification schemes 11, 12 .
At endoscopy duodenal biopsies are usually taken to exclude coeliac disease, but recent studies [6] [7] [8] [9] suggest that duodenal eosinophilia may be a marker for atopy, allergy and possibly functional dyspepsia, but not irritable bowel syndrome (IBS) 8 Eosinophils are 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60   F  o  r  P  e  e  r  R  e  v  i  e  w   5 easily visualised on sections stained by haematoxylin and eosin ( Figure 1 ) and therefore can be counted by histopathologists without the need for special stains.
The aim of this study was to audit duodenal biopsies previously reported as normal to assess eosinophil counts and correlate these with review of the clinical records, to ascertain if these cells may be a biomarker for disease states.
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Upper GI symptoms
We sought to determine the distribution of eosinophils in the context of upper GI symptoms. Patients were categorised in to the following 5 subpopulations based upon the presence and pattern of upper GI symptoms:
Group A: Patients with oesophageal symptoms, including reflux +/-retrosternal noncardiac chest pain. This group includes patients with GORD and functional oesophageal disorders (Rome III A1-4) 12 .
Group B:
Patients with symptoms of postprandial distress syndrome (ROME III B1a) 12 , including early satiety and postprandial bloating. This was a retrospective study which fulfilled criteria for audit and no study driven clinical intervention was undertaken. In keeping with national and local Research and Development guidelines this study did not require formal approval from the Local Research Ethics Committee as it was a retrospective audit of service provision.
Oesophogastroduodenoscopy and Histopathology
All endoscopies were carried out at St Mary's NHS Trust. Two independent, blinded observers assessed duodenal pathology for villous architecture; the intraepithelial lymphocyte (IEL) count and any other pathology was also noted. H. pylori infection at time of biopsy was defined as a positive histological finding of bacteria on gastric sections stained with the Gimenez stain 15 . Where gastric biopsies were not available, positive status was determined by result from diagnostic tests, either the C 13 urea breath test, or a CLO test taken at OGD.
The eosinophil count was performed in 5 randomly selected high power fields (HPFs) magnification x40 across the biopsy ( Figure 1 ). Normal was defined a priori as <22/HPFs based on a control group selected from 1001 community subjects in a previously published study 5 and normal values were calculated in the results of the biopsies from patients in the control group E above. The sum, mean and median of number of eosinophils per 5HPFs was calculated for each sample. As an internal control (intraobserver variation), the eosinophil count for the first 20 biopsies was repeated by the same observer. For external control (interobserver variation), all biopsies were re-counted by a second independent, blinded observer.
Statistical analysis
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RESULTS
Referrals
The majority of patients (59% female, mean age 55 years) attending endoscopy were referred from general practice (67%). The remainder were from outpatient clinics, inpatient ward referral and emergency OGD including the accident and emergency department. Indications for OGD included predominant upper gastrointestinal symptoms in 42%, weight loss (41%), iron deficiency anaemia (35%) and diarrhoea (34%). Patients were of diverse ethnicity, 72% were from the UK and other EU countries, 19% from Asia and the Middle East and 9% from Africa, the Caribbean and South America.
Upper Gastrointestinal Symptoms
Patients were categorised to 5 groups and categorised according to upper gastrointestinal symptom profiles and included a control population of patients without prominent upper gastrointestinal symptoms (Table 1) . It was unsurprising to find that this was the largest subgroup of patients in this study, since duodenal biopsies are commonly acquired in routine clinical practice for suspected coeliac disease. In this group 53/89 (60%) of patients had diarrhoea. Eosinophil scores are summarized in Figure 3 . Group B versus controls OR=3.1 (95% CI 0.98-9.85).
Histopathology and eosinophilia
All patient histology reports were coded as normal with no overt duodenal pathology.
None of the subjects in this audit were diagnosed with coeliac disease. 
Atopy and Allergy
Duodenal eosinophilia was significantly more common in patients with a history of allergy (OR 5.04, 95% CI 2.12-11.95, p<0.001).The overall prevalence of allergy in the study population was 20%, and just under half of all patients with duodenal eosinophilia >15/5HPFs (44%) were in this group. Twenty three had asthma; a further 8 reported hay fever and the remainder included a past medical history of eczema (n=11), urticaria (n=2), and wheat or milk food allergy (n=7). Whilst eosinophilia per se was significant in these patients, they did not have a significantly higher association of any upper GI symptom with eosinophilia (p=0.3), however group B (patients with postprandial distress syndrome) were significantly more likely to report a history of allergy versus those without upper gastrointestinal symptoms (OR 4.82, CI 1.6-14, p=0.004). The eosinophil scores are summarised in Figure 4 .
Medications
In these patients, 70% were on one or more medications, including non-steroidal antiinflammatory drugs (25%), proton pump inhibitors, (35%), (61% on both) antihypertensives,(37%), statins (20%) iron (16%), sulphonylureas, (10%) steroids, (7%) and other drugs (32%) including calcium supplementation, antiviral and immunosuppressive therapy, antiarrhythmic agents, diuretics, antidepressants, antiemetics, the oral contraceptive pill, hormone replacement therapy and compound analgesics) at the time of biopsy or in the preceding time from referral. No significant association with eosinophilia was found with any medication (p=0.1) or separate class of drugs (NSAIDs, p=0.23, PPIs p=0.78) Drug allergy (principally to penicillin) was declared by 17%, but no significant association with eosinophilia was found (p=0.62) in these patients.
Page 11 of 26
Alimentary Pharmacology & Therapeutic   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 
Seasonal variation
No significant difference was seen between eosinophil counts in biopsies taken in the autumn/ winter seasons and the spring/ summer seasons (OR 1.1, CI 0-2.9, p=0.8).
Similarly in allergy subjects, there was no significant difference either by season (OR 0.8 CI 0.2-2.7, p=0.7).
Reliability of Histopathology
Assessment of interobserver concordance in eosinophil counts showed "almost perfect agreement" with an unweighted kappa value of 0.81 (95% CI 0.65-0.97). The first 20 eosinophil counts were repeated and re-counted after all 100 counts has been performed;
the intra observer unweighted kappa was 0.53 (95% CI 0.15-0.89) and showed moderate agreement, which showed there to be a learning curve in counting eosinophils. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 9, 16 and subtle changes in numbers may be significant 17 . In the duodenum, eosinophilia has been noted in children and adults with functional dyspepsia, defined as >10/1HPF for children 16 and >22/5HPFs at the base of glands for adults 5 . In this study, we have audited eosinophilia in duodenal biopsies from 155 adult patients attending for OGD, and observed a significant association between duodenal eosinophil numbers and a history of allergy and post prandial distress most notably early satiety.
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Previous studies in patients with allergy and atopy have shown that these patients have gastrointestinal symptoms 6, 7, 18 and that eosinophils may be implicated in functional dyspepsia 8, 19 . These results strengthen the hypothesis that hypersensitivity underlies gastrointestinal disorders in a subset of patients. It is possible that eosinophils contribute to an altered local cytokine environment, causing visceral symptoms in the upper abdomen. Seasonal variation may be important, as duodenal mucosal eosinophils have been shown to increase in the birch pollen season in one study 20 however; we found no significant difference by season of biopsy, which has also been shown in biopsies of colonic mucosa in patients without colitis undergoing cancer screening taken during seasonal elevations in pollen counts 21 .
Early satiety is a classical symptom of dyspepsia 11, 22 . Our analysis demonstrates a significant association between eosinophils and this symptom although the number included was modest. We have previously also observed that duodenal eosinophilia was specifically linked to early satiety 5 . There were no other causes for eosinophilia in the patients in the present study reporting early satiety; all were H. pylori negative, with no parasite infection, malignancy, and inflammation; further, raised IEL counts and coeliac disease were excluded. Of these patients, one had a hiatus hernia, with the remaining 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 although not statistically significant link to dyspepsia as a symptom cluster, suggesting that eosinophilia may be a marker of certain pathologies in these disorders. However, our study was not powered to assess the link to dyspepsia, and further work is needed to evaluate the association of duodenal eosinophilia with specific dyspepsia symptoms.
Dyspepsia is a constellation of symptoms, and fruitful work may come from further investigation of those with early satiety as the predominant complaint rather than placing these all into the functional dyspepsia category. Early satiety may be due to neurological dysfunction, which we postulate might be caused by eosinophil mediated axonal necrosis, as seen in murine eosinophil gastrointestinal disorder models 23 and eosinophil interference with muscarinic receptors. Major basic protein (MBP) released from eosinophil degranulation can induce vagal M2 receptor dysfunction increasing smooth muscle reactivity 24 . Importantly, eosinophil stimulated T cell activation and mast cell degranulation releases lipid mediators, leukotrienes, which are a potent stimulator of smooth muscle contraction 19 ( Figure 5 ).
The lack of association of medication is not perhaps surprising in view of few reports of drug induced eosinophilic gastroenteritis 25 . The majority of patients (70%) were on one or more medications, and no association of eosinophilia noted with any class of medication. Whilst an association with use of proton pump inhibitors and the emergence of eosinophilic oesophagitis has been mooted 26 , duodenal eosinophilia was not associated with use of this drug in these patients, even though a significant proportion of patients (35%) were on this therapy.
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